Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Nymox Pharm Corp (NYMX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 177,101
  • Shares Outstanding, K 54,830
  • Annual Sales, $ 280 K
  • Annual Income, $ -13,110 K
  • 36-Month Beta 0.83
  • Price/Sales 1,032.63
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.05 +5.90%
on 01/09/18
3.59 -10.03%
on 01/03/18
-0.30 (-8.50%)
since 12/15/17
3-Month
3.05 +5.90%
on 01/09/18
4.00 -19.25%
on 10/18/17
-0.72 (-18.23%)
since 10/17/17
52-Week
2.80 +15.36%
on 01/31/17
5.10 -36.67%
on 04/26/17
+0.13 (+4.19%)
since 01/17/17

Most Recent Stories

More News
Nymox Fexapotide Symposium and Panel Discussion at American Urological Association South Central Sectional Annual Meeting in Naples FL

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report on the Symposium which was held on Fexapotide Triflutate studies at the Annual Meeting of the American Urological Association, South...

NYMX : 3.23 (-0.31%)
Nymox Fexapotide Symposium and Panel Discussion at American Urological Association North Central Sectional Annual Meeting in Scottsdale

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report on the Symposium which was held on Fexapotide Triflutate studies at the Annual Meeting of the American Urological Association, North...

NYMX : 3.23 (-0.31%)
Nymox Reports on Symposium, Panel Discussion and Podium Presentation on Fexapotide at American Urological Association New York Section Annual Meeting in Havana

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report on the two data presentations which were held on Fexapotide Triflutate studies at the Annual Meeting of the American Urological Association,...

NYMX : 3.23 (-0.31%)
Nymox Announces Two Data Presentations for Company's BPH Drug at New York American Urological Association Meeting November 6

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that two data presentations of the Company's new drug Fexapotide Triflutate will be held at the November meeting of the American Urological...

NYMX : 3.23 (-0.31%)
Nymox Reports on Symposium and Panel Discussion on Fexapotide at American Urological Association Northeast Sectional Annual Meeting in Savannah October 12

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report on the Symposium on Fexapotide Triflutate studies to be held at the Annual Meeting of the American Urological Association Northeastern...

NYMX : 3.23 (-0.31%)
Nymox Announces October 12 Symposium for Company's BPH Drug at American Urological Association Meeting

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that an important large symposium and panel assessment of the Company's new drug Fexapotide Triflutate will be held at the October...

NYMX : 3.23 (-0.31%)
Nymox Application Validated:

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce today that the European Member States for Nymox's Marketing Authorization Application (MAA) for Fexapotide Triflutate for the treatment...

NYMX : 3.23 (-0.31%)
Nymox Announces New Symposium for Company's BPH Drug at American Urological Association Meeting October 5

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that an important large symposium and panel assessment of the Company's new drug Fexapotide Triflutate will be held at the October...

NYMX : 3.23 (-0.31%)
Nymox Announces Private Placements of $3 Million

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce recent completion of private placements with proceeds totaling US $3.0 million. There were no warrants or fees associated with the...

NYMX : 3.23 (-0.31%)
Sexual Function Improves in First-Line Patients Given Fexapotide Treatment in Nymox U.S. BPH Long-Term Clinical Trials

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce statistically significant clinical trial results showing that the Company's prostate enlargement (BPH) and prostate cancer drug Fexapotide...

NYMX : 3.23 (-0.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Nymox Pharmaceutical Corporation is engaged in the research and development of drugs and diagnostic products. The company offers products such as AlzheimAlert, NicAlert and TobacAlert tests. It markets its products primarily in the United States, Canada, and Europe. Nymox Pharmaceutical Corporation is...

See More

Key Turning Points

2nd Resistance Point 3.40
1st Resistance Point 3.31
Last Price 3.23
1st Support Level 3.17
2nd Support Level 3.12

See More

52-Week High 5.10
Fibonacci 61.8% 4.22
Fibonacci 50% 3.95
Fibonacci 38.2% 3.68
Last Price 3.23
52-Week Low 2.80

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.